Codiak Bioscience News Today

Moderna (NASDAQ:MRNA – Get Free Report) and Codiak BioSciences (NASDAQ:CDAK – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Moderna and Codiak BioSciences’ net […]

Sutro Biopharma (NASDAQ:STRO – Free Report) and Codiak BioSciences (NASDAQ:CDAK – Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Profitability This table compares Sutro Biopharma and Codiak BioSciences’ […]

Oxford-based biotech Evox therapeutics, a leader in harnessing and engineering the natural delivery capabilities of extracellular vesicles (EVs), known as exosomes, has purchased Codiak Biosciences’ engEx-AAV™ technology platform. Click to read more...

BioNTech (NASDAQ:BNTX – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership. Valuation and Earnings This table compares BioNTech and Codiak BioSciences’ revenue, […]

Harpoon Therapeutics (NASDAQ:HARP – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Insider and Institutional Ownership 65.5% of Harpoon Therapeutics shares […]

Entera Bio (NASDAQ:ENTX – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation. Valuation & Earnings This table compares Entera Bio and […]

Codiak BioSciences (NASDAQ:CDAK – Get Rating) and Century Therapeutics (NASDAQ:IPSC – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations. Institutional and Insider Ownership 71.3% of Codiak BioSciences shares […]

Gamida Cell (NASDAQ:GMDA – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]

Lonza has been investing in developing exosome manufacturing and characterization technologies for the past five years, and this week it ramped up its focus on that category by acquiring two sites.

To grapple with slippery, shapeshifting cancer targets, developers are trying new holds, tag-teaming with the immune system, and even hitting below the translational belt.